Tilray Brands (TLRY) Tax Provisions (2018 - 2026)
Tilray Brands' (TLRY) quarterly Tax Provisions came in at -$21.7 million in Q2 2026, up 95.55% YoY from -$11.1 million in Q2 2025, and down 1200.66% on a QoQ basis from $2.0 million in Q1 2026.
Tilray Brands (TLRY) Tax Provisions (2018 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 9 years of Tax Provisions data on file, last reported at -$21.7 million in Q2 2026.
- Quarterly Tax Provisions rose 95.55% year-over-year to -$21.7 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$18.5 million (up 96.18% YoY) and the FY2026 annual result came in at -$18.5 million, up 96.18% from the prior year.
- Tax Provisions eased to -$21.7 million in Q2 2026, from $2.0 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $11.7 million in Q4 2022 to a low of -$487.8 million in Q2 2025.
- A 5-year average of -$51.5 million and a median of -$2.1 million in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions jumped 306.54% — and 2025, when it sank 832.08%.
- Tracing TLRY's Tax Provisions over 5 years: stood at $11.7 million in 2022, then plunged by 128.86% to -$3.4 million in 2023, then soared by 160.24% to $2.0 million in 2024, then jumped by 74.17% to $3.5 million in 2025, then sank by 712.72% to -$21.7 million in 2026.
- The last three Tax Provisions figures came in at -$21.7 million (Q2 2026), $2.0 million (Q1 2026), and $3.5 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | -21.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -21.73 Mn |
| Feb 28, 2026 | 1.97 Mn |
| Nov 30, 2025 | 3.55 Mn |
| Aug 31, 2025 | -2.29 Mn |
| May 31, 2025 | -487.83 Mn |
| Feb 28, 2025 | 1.20 Mn |
| Nov 30, 2024 | 2.04 Mn |
| Aug 31, 2024 | 886,000.00 |
| May 31, 2024 | -52.34 Mn |
| Feb 29, 2024 | -2.87 Mn |
| Nov 30, 2023 | -3.38 Mn |
| Aug 31, 2023 | 7.26 Mn |
| May 31, 2023 | -289.23 Mn |
| Feb 28, 2023 | -10.81 Mn |
| Nov 30, 2022 | 11.71 Mn |
| Aug 31, 2022 | 7.21 Mn |
| May 31, 2022 | -89.80 Mn |
| Feb 28, 2022 | -1.83 Mn |
| Nov 30, 2021 | -5.67 Mn |
| Aug 31, 2021 | 4.76 Mn |